Although effectively used to treat incurable, life-threatening diseases like Diabetes, Cancer, Arthritis etc., Protein based drugs (Biologics) can cost up to twenty-two times more than traditional small-molecule medicines. Since Biologics are mostly used to treat illnesses that require continual treatment, it makes them very unaffordable for patients of developing countries.
At Magellan Biologix™ we are focused on catering to this need for affordable Biologics. Our proprietary technology for production of these Biologics, Magellan X-Ceed™ (Patent pending), is time and cost efficient with extremely competitive yield to cost benefits.
Our proprietary Magellan X-Ceed™ (Patent Pending) platform facilitates recombinant protein based food additives/supplements on an industrial scale with extremely competitive cost to yield benefits. The salient features of Magellan X-Ceed™ (Patent Pending) are as follows:
- Based on proprietary chaperone molecule.
- Very high expression levels of proteins of interest
- Heat stable properties
- Simplified down stream purification
Parathyroid Hormone (PTH)